ARM3 FOURTH QUARTER REPORT _________________________________________________________________ FISCAL YEAR 2012 – QUARTER 4 JULY 1 – SEPT 30, 2012 Participants in Abomey during the IMCI training . October 30, 2012 This report was produced for the United States Agency for International Development (USAID) by Medical Care Development International (MCDI). ARM3 Accelerating the Reduction of Malaria Morbidity and Mortality Program Fourth Quarter Report July 1, 2012 to September 30, 2012 Fiscal Year 2012 Submitted to: Dr. Emile Bongo, USAID Agreement Officer Representative (AOR), USAID/Benin Dr. Milton Amayun, Family Health Team Leader, USAID/Benin Ms. Anne Busaka, Senior Acquisition and Assistance Specialist, USAID/Benin ARM3, Accelerating the Reduction of Malaria Morbidity and Mortality Program (ARM3), is funded by the United States Agency for International Development (USAID), under Cooperative Agreement AID-680-A-11-00001. ARM3 is managed by Medical Care Development International (MCDI) as the prime, in collaboration with sub-grantees Africare, Johns – Hopkins University – Center for Communications Project (JHU-CCP) and Management Sciences for Health (MSH). The author’s views expressed in this publication do not necessarily reflect the views of the United States Agency for International Development or of the United States Government. Table of Contents Table of Contents .......................................................................................................................................... 1 Table of Acronyms ........................................................................................................................................ 1 Acknowledgements ....................................................................................................................................... 3 Executive Summary ...................................................................................................................................... 4 Introduction.................................................................................................................................................... 6 Start-up Activities (continued) ....................................................................................................................... 6 Achievements ........................................................................................................................................ 6 Result 1: Implementation of malaria prevention interventions in support of the National Malaria Strategy improved........................................................................................................................................................ 8 Sub-Result 1.1: IPTp Uptake Increased ........................................................................................................................................ 8 Achievements ........................................................................................................................................ 8 Results .................................................................................................................................................. 9 Sub-Result 1.2: Supply and Use of LLINs Increased ..................................................................................................................... 9 Achievements ...................................................................................................................................... 10 Results ................................................................................................................................................ 10 Result 2: Malaria diagnosis and treatment activities in support of the National Malaria Strategy improved 11 Sub-Result 2.1: Diagnostic Capacity and Use of Testing Improved ............................................................................................. 11 Achievements ...................................................................................................................................... 11 Results ................................................................................................................................................ 13 Sub-Result 2.2: Case Management of Uncomplicated and Severe Malaria Improved ................................................................. 13 Achievements ...................................................................................................................................... 13 Results ................................................................................................................................................ 16 Result 3: The national health system’s capacity to deliver and manage quality malaria treatment and control interventions strengthened. ............................................................................................................. 17 Sub-Result 3.1: MOH/NMCP Capacity to Deliver and Manage Quality Malaria Treatment and Control Interventions Improved .. 17 Achievements ...................................................................................................................................... 17 Results ................................................................................................................................................ 18 Sub-Result 3.2: Capacity to Collect, Manage and Use Malaria Health Information for M&E and Surveillance Improved .............. 19 Achievements ...................................................................................................................................... 19 Results ................................................................................................................................................ 22 Sub-Result 3.3: Capacity in Commodities and Supply Chain Management Improved ................................................................. 22 Achievements ...................................................................................................................................... 23 Cross Sectional Activities ............................................................................................................................ 26 Behavior Change Communication (BCC) .................................................................................................................................... 26 Achievements ...................................................................................................................................... 26 Performance Improvement Approach .......................................................................................................................................... 28 Achievements ...................................................................................................................................... 28 Program Management ................................................................................................................................ 30 Home Office Backstopping and Reporting................................................................................................................................... 30 Achievements ...................................................................................................................................... 30 Major Challenges (per ARM3 sub-result): ................................................................................................... 31 Major Activities Planned for next quarter (Oct– Dec): ................................................................................. 32 Financial Summary ..................................................................................................................................... 34 Annex 1: OTSS Data – Round 9 (Group D Baseline) vs. Round 8 (Comparison Groups A, B, and C) ..... 35 ANNEX 2: SUMMARY OF PRELIMINARY RESULTS OF THE APRIL 2012 END-USE VERIFICATION SURVEY...................................................................................................................................................... 47 ANNEX 3: MINI CARAVAN QUOTES ........................................................................................................ 54 Annex 4: ARM3 Quarterly Financial Report (July through September 2012), Reporting from Inception (October 3, 2011) through September 30, 2012 – Cumulative ................................................................... 56 Annex 5: ARM3 Quarterly Financial Report (July through September) Reporting from July 1 through September 30, 2012 – Non Cumulative ...................................................................................................... 57 Table of Acronyms AAA/3A Akpro Misserte – Avrankou – Adjarra ABC Analysis of stock value, turnover, and volume ABD Adjohoun – Bonou -- Dangbo ABFC Association Béninoise de Femmes Chanteuses ACPB Association des Cliniques Privées du Bénin ACT Artemisinin Combination Therapy AIRS Abt’s Indoor Residual Spraying Program AL Artemether + Lumefantrin AMCES Association des Œuvres Médicales Privées Confessionnelles et Sociales ANC Antenatal Clinic AOR Agreement Officer Representative ARM3 Accelerating the Reduction of Malaria Morbidity and Mortality Program (ARM3) BASICS Basic Support for Institutionalizing Child Survival BCC Behavioral Change Communication BDHS Benin Demographic and Health Survey CAFE Stock Management Software Company CAME Centrale d’Achat des Médicaments Essentiels (Central Medical